Literature DB >> 22052579

Early diagnosis of lung cancer: evaluation of a community-based social marketing intervention.

Victoria L Athey1, Rupert J Suckling, Angela M Tod, Stephen J Walters, Trevor K Rogers.   

Abstract

BACKGROUND: Poor U.K. lung cancer survival rates may, in part, be due to late diagnosis.
OBJECTIVES: To evaluate the effectiveness of a mixed-method community-based social marketing intervention on lung cancer diagnoses.
METHODS: A public awareness campaign in conjunction with brief intervention training in general practices was piloted in six localities with a high lung cancer incidence. End points were self-reported awareness of lung cancer symptoms; intention to seek healthcare; chest x-ray referral rates in primary care; secular trends in the incidence of lung cancer and stage at diagnosis, compared before and after the intervention.
RESULTS: 21% (128/600) (95% CI 18% to 25%) of the targeted population recalled something about the campaign. Compared with a responder in the control area, the odds of a responder in the intervention area saying that they would visit their general practitioner and request a chest x-ray for a cough was 1.97 times (95% CI 1.18 to 3.31, p=0.01). Primary care chest x-ray referral rates increased by 20% in the targeted practices in the year following the intervention compared with a 2% fall in the control practices. The difference was highly significant, with an incidence rate ratio of 1.22 (95% CI 1.12 to 1.33, p=0.001). There was a 27% increase in lung cancer diagnoses in the intervention area compared with a fall in the control area. The incidence rate ratio was 1.42 (95% CI 0.83 to 2.44 p=0.199).
CONCLUSION: This is encouraging early evidence that an awareness and early recognition initiative may facilitate lung cancer diagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 22052579     DOI: 10.1136/thoraxjnl-2011-200714

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  36 in total

1.  Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.

Authors:  Rong Li; Jiang Gu; John V Heymach; Xiang Shu; Lina Zhao; Baohui Han; Yuanqing Ye; Jack Roth; Xifeng Wu
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

2.  Reducing the time before consulting with symptoms of lung cancer: a randomised controlled trial in primary care.

Authors:  Sarah Smith; Shona Fielding; Peter Murchie; Marie Johnston; Sally Wyke; Rachael Powell; Graham Devereux; Marianne Nicolson; Una Macleod; Phil Wilson; Lewis Ritchie; Amanda J Lee; Neil C Campbell
Journal:  Br J Gen Pract       Date:  2013-01       Impact factor: 5.386

Review 3.  Improving early diagnosis of symptomatic cancer.

Authors:  Willie Hamilton; Fiona M Walter; Greg Rubin; Richard D Neal
Journal:  Nat Rev Clin Oncol       Date:  2016-07-26       Impact factor: 66.675

4.  Lung cancer diagnosed following an emergency admission: exploring patient and carer perspectives on delay in seeking help.

Authors:  Glenys Caswell; Jane Seymour; Vincent Crosby; Asmah Hussain; Cathann Manderson; Sarah Farnan; Sarah Freer; Alison Freemantle; Fran Littlewood; Andrew Wilcock
Journal:  Support Care Cancer       Date:  2017-02-21       Impact factor: 3.603

Review 5.  A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms.

Authors:  Mohamad M Saab; Megan McCarthy; Michelle O'Driscoll; Laura J Sahm; Patricia Leahy-Warren; Brendan Noonan; Serena FitzGerald; Maria O'Malley; Noreen Lyons; Heather E Burns; Una Kennedy; Áine Lyng; Josephine Hegarty
Journal:  NPJ Prim Care Respir Med       Date:  2022-10-18       Impact factor: 3.289

6.  Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line.

Authors:  Mohammad Rahmati-Yamchi; Somayyeh Ghareghomi; Gholamreza Haddadchi; Morteza Milani; Mohammad Aghazadeh; Hasan Daroushnejad
Journal:  Mol Biol Rep       Date:  2014-06-29       Impact factor: 2.316

7.  Protocol for the CHEST Australia Trial: a phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer.

Authors:  Sonya R Murray; Peter Murchie; Neil Campbell; Fiona M Walter; Danielle Mazza; Emily Habgood; Yvonne Kutzer; Andrew Martin; Stephen Goodall; David J Barnes; Jon D Emery
Journal:  BMJ Open       Date:  2015-05-18       Impact factor: 2.692

8.  The Improving Rural Cancer Outcomes (IRCO) Trial: a factorial cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural patients with cancer in Western Australia: a study protocol.

Authors:  Jon D Emery; Victoria Gray; Fiona M Walter; Shelley Cheetham; Emma J Croager; Terry Slevin; Christobel Saunders; Tim Threlfall; Kirsten Auret; Anna K Nowak; Elizabeth Geelhoed; Max Bulsara; C D'Arcy J Holman
Journal:  BMJ Open       Date:  2014-09-17       Impact factor: 2.692

9.  Increasing awareness of gynaecological cancer symptoms: a GP perspective.

Authors:  Ruth E C Evans; Melanie Morris; Mandeep Sekhon; Marta Buszewicz; Fiona M Walter; Jo Waller; Alice E Simon
Journal:  Br J Gen Pract       Date:  2014-06       Impact factor: 5.386

10.  Risk factors for delay in symptomatic presentation: a survey of cancer patients.

Authors:  L J L Forbes; F Warburton; M A Richards; A J Ramirez
Journal:  Br J Cancer       Date:  2014-06-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.